Loading...
Market
How many people will benefit from China's drug price cuts by end of 2025?
2
Resolution / Starting Odds
Less than 850 million • 25%
850 million to 900 million • 25%
900 million to 950 million • 25%
More than 950 million • 25%
Reports from China's National Healthcare Security Administration
Story
China Cuts Drug Prices by 63%, Adding 91 New Drugs to Insurance List, Benefiting 830 Million People
Nov 28, 2024, 07:30 AM
China's National Healthcare Security Administration announced a significant update to its national medical insurance drug list, which now includes 91 new drugs. These drugs will see an average price reduction of 63%, leading to an estimated decrease in patient costs of over 50 billion yuan (approximately $6.95 billion) in 2025. The administration reported that, as of October 2024, medication price negotiations have benefited 830 million people and reduced the cumulative financial burden on patients by CNY 880 billion (around $121.5 billion) over the past seven years. This initiative is part of China's broader efforts to expand drug coverage and improve healthcare affordability for its citizens.
View original story
Similar markets
Less than 5 million • 25%
5 million to 7 million • 25%
7 million to 9 million • 25%
More than 9 million • 25%
Less than $6 billion • 25%
$6 billion to $7 billion • 25%
$7 billion to $8 billion • 25%
More than $8 billion • 25%
10 drugs • 25%
11-15 drugs • 25%
16-20 drugs • 25%
More than 20 drugs • 25%
Less than $4 billion • 25%
$4 billion to $5 billion • 25%
$5 billion to $6 billion • 25%
More than $6 billion • 25%
Elderly • 25%
Children • 25%
Unemployed • 25%
Disabled • 25%
Less than $5 billion • 25%
$5 billion to $6 billion • 25%
$6 billion to $7 billion • 25%
More than $7 billion • 25%
Less than 15% • 25%
15% to 20% • 25%
20% to 25% • 25%
More than 25% • 25%
0-10% • 25%
11-20% • 25%
21-30% • 25%
Above 30% • 25%
Yes • 50%
No • 50%
< 1 million • 33%
1 - 2 million • 33%
> 2 million • 34%
Yes • 50%
No • 50%